DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Losoxantrone
Losoxantrone
Download
Tanibirumab (CUI C3490677) Add to Cart
C19) United States 02) Patent Application Publication (10) Pub
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(12) United States Patent (10) Patent No.: US 9,062,029 B2 Schadt Et Al
Use of Chk2 Kinase Inhibitors for Cancer Treatment
Marrakesh Agreement Establishing the World Trade Organization
Curriculum Vitae
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
Synthesis and Biological Activity of Novel Tu100 Derivatives
A Phase I and Pharmacokinetic Study of Losoxantrone and Paclitaxel in Patients with Advanced Solid Tumors1
Stembook 2018.Pdf
Synthesis, Dna Interactions and Activation of Novel Cytotoxic Anthraquinones
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Marrakesh Agreement Establishing the World Trade Organization
Pharmaceutical Compositions and Dosage Forms of Thalidomide
Bidirectional Interplay of Nutrition and Chemotherapy
Top View
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
United States Patent $835 a 88: As: Inhibitor 1-((R)-3-(4-Amino-3-(4
Inhibitors of the Menin-Mll Interaction Inhibitoren Der Menin-Mll-Interaktion Inhibiteurs De L’Interaction Ménine-Mll
Phase I Study of the Combination of Losoxantrone and Cyclophosphamide in Patients with Refractory Solid Tumours
Factors Determining Sensitivity and Resistance of Tumor Cells to Arsenic Trioxide
Pharmaabkommen A1 E
C12) United States Patent (IO) Patent No.: US 9,777,013 B2 Nicolaou Et Al
Curriculum Vitae
Customs Tariff - Schedule Xxi - 1
Therapeutic Polymeric Nanoparticle Compositions
United States (12) Patent Application Publication (Io) Pub
(2006.01) C07d 413/14
(12) Patent Application Publication (10) Pub. No.: US 2010/0226943 A1 Brennan Et Al
Harmonized Tariff Schedule of the United States (2006) (Rev
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Customs Tariff - Schedule Xxi - 1
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
Arylquinoline and Analog Compounds and Use Thereof to Treat Cancer David S
In Vitro Cytotoxic Activity of Anthrapyrazole Analogues in Human Prostate DU-145 and Testicular NTERA-2 Carcinoma Cells
Compositions for Treating Breast Cancer
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Recent Patents on Live Bacteria and Their Products As Potential Anti- Cancer Agents
Mechanisms of Action and Reduced Cardiotoxicity of Pixantrone; a Topoisomerase II Targeting Agent with Cellular Selectivity for the Topoisomerase Iia Isoform S
) (51) International Patent Classification: C07D 405/14
WO 2017/035116 Al O
2U11/135459 A2
(12) United States Patent (10) Patent No.: US 8,318,163 B2 Appleton Et Al
Pharmaceutical Appendix to the Tariff Schedule 2
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
Khanh Tuan Tran Submitted to the Faculty of Graduate Studies
Combinations of an Anti-HER2 Antibody-Drug Conjugate and Docetaxel